Skip to main content
Table of Contents
Print

What side effects outweigh cannabis’s sleep apnoea benefits? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Research suggests cannabis may help regulate breathing patterns, questions remain about the safety of using cannabis for apnoea  and its side effects. 

The debate around risks vs benefits of cannabis is especially important when it comes to sleep disorders. Though cannabinoids like THC may reduce certain symptoms, their impact on overall sleep quality and long-term health is less clear. Understanding what side effects might outweigh potential benefits is crucial for anyone considering this treatment option. 

Potential Side Effects to Consider 

Before looking at the positives, it’s important to recognise the safety concerns. People with OSA must carefully weigh up the use of cannabis for apnoea and side effects alongside existing medical advice. 

Daytime fatigue 

Some users report lingering drowsiness or grogginess, which may worsen daytime sleepiness already linked to apnoea. 

Cognitive impact 

THC can impair memory, focus, and reaction time. For those managing OSA, this raises concerns about alertness during daily activities. 

Respiratory irritation 

Smoking or vaping cannabis may aggravate the airways, which could make OSA and cannabis safety more complex. 

Dependency risks 

Regular use of cannabis may lead to dependency, creating additional challenges for long-term health management. 

In summary, while medical cannabis may show promise, the potential side effects can outweigh the benefits in certain cases, especially for people with sleep apnoea. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories